nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—ABCC1—Zoledronate—osteoporosis	0.213	0.287	CbGbCtD
Saxagliptin—ABCC1—Conjugated Estrogens—osteoporosis	0.118	0.16	CbGbCtD
Saxagliptin—SLC22A8—Conjugated Estrogens—osteoporosis	0.0919	0.124	CbGbCtD
Saxagliptin—SLC22A8—Estradiol—osteoporosis	0.0807	0.109	CbGbCtD
Saxagliptin—CYP3A5—Estradiol—osteoporosis	0.0385	0.0519	CbGbCtD
Saxagliptin—CYP3A4—Estropipate—osteoporosis	0.0361	0.0488	CbGbCtD
Saxagliptin—CYP3A4—Calcitriol—osteoporosis	0.0361	0.0488	CbGbCtD
Saxagliptin—CYP3A4—Ergocalciferol—osteoporosis	0.0289	0.039	CbGbCtD
Saxagliptin—CYP3A4—Raloxifene—osteoporosis	0.0241	0.0325	CbGbCtD
Saxagliptin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0233	0.0314	CbGbCtD
Saxagliptin—CYP3A4—Cholecalciferol—osteoporosis	0.0186	0.0251	CbGbCtD
Saxagliptin—CYP3A4—Conjugated Estrogens—osteoporosis	0.0171	0.0231	CbGbCtD
Saxagliptin—CYP3A4—Estradiol—osteoporosis	0.015	0.0202	CbGbCtD
Saxagliptin—Anaphylactic shock—Estropipate—osteoporosis	0.000697	0.00269	CcSEcCtD
Saxagliptin—Infection—Estropipate—osteoporosis	0.000693	0.00268	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000693	0.00268	CcSEcCtD
Saxagliptin—Malnutrition—Ethinyl Estradiol—osteoporosis	0.000693	0.00268	CcSEcCtD
Saxagliptin—Myalgia—Calcitriol—osteoporosis	0.000683	0.00264	CcSEcCtD
Saxagliptin—Infection—Alendronate—osteoporosis	0.000682	0.00264	CcSEcCtD
Saxagliptin—Sinusitis—Conjugated Estrogens—osteoporosis	0.000678	0.00262	CcSEcCtD
Saxagliptin—Skin disorder—Estropipate—osteoporosis	0.000677	0.00262	CcSEcCtD
Saxagliptin—Malnutrition—Risedronate—osteoporosis	0.000675	0.00261	CcSEcCtD
Saxagliptin—Infection—Raloxifene—osteoporosis	0.000671	0.00259	CcSEcCtD
Saxagliptin—Nasopharyngitis—Estradiol—osteoporosis	0.000671	0.00259	CcSEcCtD
Saxagliptin—Anaphylactic shock—Ibandronate—osteoporosis	0.000669	0.00258	CcSEcCtD
Saxagliptin—Immune system disorder—Pamidronate—osteoporosis	0.000666	0.00257	CcSEcCtD
Saxagliptin—Flatulence—Risedronate—osteoporosis	0.000665	0.00257	CcSEcCtD
Saxagliptin—Infection—Ibandronate—osteoporosis	0.000664	0.00257	CcSEcCtD
Saxagliptin—Gastritis—Estradiol—osteoporosis	0.000664	0.00257	CcSEcCtD
Saxagliptin—Oedema peripheral—Zoledronate—osteoporosis	0.000664	0.00256	CcSEcCtD
Saxagliptin—Thrombocytopenia—Raloxifene—osteoporosis	0.000661	0.00255	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000659	0.00255	CcSEcCtD
Saxagliptin—Skin disorder—Raloxifene—osteoporosis	0.000656	0.00253	CcSEcCtD
Saxagliptin—Anaphylactic shock—Calcitriol—osteoporosis	0.000655	0.00253	CcSEcCtD
Saxagliptin—Skin disorder—Ibandronate—osteoporosis	0.00065	0.00251	CcSEcCtD
Saxagliptin—Nausea—Ergocalciferol—osteoporosis	0.000644	0.00249	CcSEcCtD
Saxagliptin—Malnutrition—Pamidronate—osteoporosis	0.000642	0.00248	CcSEcCtD
Saxagliptin—Urticaria—Etidronic acid—osteoporosis	0.00064	0.00247	CcSEcCtD
Saxagliptin—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000639	0.00247	CcSEcCtD
Saxagliptin—Abdominal pain—Etidronic acid—osteoporosis	0.000637	0.00246	CcSEcCtD
Saxagliptin—Skin disorder—Calcitriol—osteoporosis	0.000636	0.00246	CcSEcCtD
Saxagliptin—Pancreatitis—Estradiol—osteoporosis	0.000636	0.00246	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000635	0.00245	CcSEcCtD
Saxagliptin—Angioedema—Ethinyl Estradiol—osteoporosis	0.000633	0.00244	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000626	0.00242	CcSEcCtD
Saxagliptin—Angioedema—Risedronate—osteoporosis	0.000617	0.00238	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000616	0.00238	CcSEcCtD
Saxagliptin—Dyspepsia—Estropipate—osteoporosis	0.000614	0.00237	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000609	0.00235	CcSEcCtD
Saxagliptin—Immune system disorder—Zoledronate—osteoporosis	0.000608	0.00235	CcSEcCtD
Saxagliptin—Dyspepsia—Alendronate—osteoporosis	0.000605	0.00234	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Estradiol—osteoporosis	0.000603	0.00233	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Estropipate—osteoporosis	0.000602	0.00233	CcSEcCtD
Saxagliptin—Fatigue—Estropipate—osteoporosis	0.000601	0.00232	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000596	0.0023	CcSEcCtD
Saxagliptin—Dyspepsia—Raloxifene—osteoporosis	0.000595	0.0023	CcSEcCtD
Saxagliptin—Hypersensitivity—Etidronic acid—osteoporosis	0.000594	0.00229	CcSEcCtD
Saxagliptin—Dyspepsia—Ibandronate—osteoporosis	0.000589	0.00227	CcSEcCtD
Saxagliptin—Angioedema—Pamidronate—osteoporosis	0.000587	0.00227	CcSEcCtD
Saxagliptin—Malnutrition—Zoledronate—osteoporosis	0.000586	0.00227	CcSEcCtD
Saxagliptin—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000586	0.00226	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000586	0.00226	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000583	0.00225	CcSEcCtD
Saxagliptin—Infestation NOS—Estradiol—osteoporosis	0.000578	0.00223	CcSEcCtD
Saxagliptin—Infestation—Estradiol—osteoporosis	0.000578	0.00223	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000577	0.00223	CcSEcCtD
Saxagliptin—Fatigue—Ibandronate—osteoporosis	0.000577	0.00223	CcSEcCtD
Saxagliptin—Arthralgia—Risedronate—osteoporosis	0.000575	0.00222	CcSEcCtD
Saxagliptin—Myalgia—Risedronate—osteoporosis	0.000575	0.00222	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000571	0.00221	CcSEcCtD
Saxagliptin—Pruritus—Etidronic acid—osteoporosis	0.00057	0.0022	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Estropipate—osteoporosis	0.00057	0.0022	CcSEcCtD
Saxagliptin—Malnutrition—Conjugated Estrogens—osteoporosis	0.000565	0.00218	CcSEcCtD
Saxagliptin—Urinary tract infection—Estradiol—osteoporosis	0.000562	0.00217	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Alendronate—osteoporosis	0.000562	0.00217	CcSEcCtD
Saxagliptin—Infection—Ethinyl Estradiol—osteoporosis	0.000562	0.00217	CcSEcCtD
Saxagliptin—Flatulence—Conjugated Estrogens—osteoporosis	0.000556	0.00215	CcSEcCtD
Saxagliptin—Urticaria—Estropipate—osteoporosis	0.000554	0.00214	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Raloxifene—osteoporosis	0.000552	0.00213	CcSEcCtD
Saxagliptin—Abdominal pain—Estropipate—osteoporosis	0.000551	0.00213	CcSEcCtD
Saxagliptin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000549	0.00212	CcSEcCtD
Saxagliptin—Infection—Risedronate—osteoporosis	0.000548	0.00212	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Ibandronate—osteoporosis	0.000547	0.00211	CcSEcCtD
Saxagliptin—Myalgia—Pamidronate—osteoporosis	0.000547	0.00211	CcSEcCtD
Saxagliptin—Arthralgia—Pamidronate—osteoporosis	0.000547	0.00211	CcSEcCtD
Saxagliptin—Urticaria—Alendronate—osteoporosis	0.000546	0.00211	CcSEcCtD
Saxagliptin—Abdominal pain—Alendronate—osteoporosis	0.000543	0.0021	CcSEcCtD
Saxagliptin—Sinusitis—Estradiol—osteoporosis	0.000543	0.0021	CcSEcCtD
Saxagliptin—Angioedema—Zoledronate—osteoporosis	0.000536	0.00207	CcSEcCtD
Saxagliptin—Skin disorder—Risedronate—osteoporosis	0.000535	0.00207	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000535	0.00207	CcSEcCtD
Saxagliptin—Abdominal pain—Raloxifene—osteoporosis	0.000534	0.00206	CcSEcCtD
Saxagliptin—Urticaria—Ibandronate—osteoporosis	0.000531	0.00205	CcSEcCtD
Saxagliptin—Abdominal pain—Ibandronate—osteoporosis	0.000529	0.00204	CcSEcCtD
Saxagliptin—Anaphylactic shock—Pamidronate—osteoporosis	0.000524	0.00202	CcSEcCtD
Saxagliptin—Infection—Pamidronate—osteoporosis	0.000521	0.00201	CcSEcCtD
Saxagliptin—Urticaria—Calcitriol—osteoporosis	0.00052	0.00201	CcSEcCtD
Saxagliptin—Abdominal pain—Calcitriol—osteoporosis	0.000518	0.002	CcSEcCtD
Saxagliptin—Angioedema—Conjugated Estrogens—osteoporosis	0.000516	0.00199	CcSEcCtD
Saxagliptin—Hypersensitivity—Estropipate—osteoporosis	0.000514	0.00198	CcSEcCtD
Saxagliptin—Thrombocytopenia—Pamidronate—osteoporosis	0.000513	0.00198	CcSEcCtD
Saxagliptin—Vomiting—Etidronic acid—osteoporosis	0.000513	0.00198	CcSEcCtD
Saxagliptin—Oedema peripheral—Estradiol—osteoporosis	0.000511	0.00198	CcSEcCtD
Saxagliptin—Rash—Etidronic acid—osteoporosis	0.000508	0.00196	CcSEcCtD
Saxagliptin—Dermatitis—Etidronic acid—osteoporosis	0.000508	0.00196	CcSEcCtD
Saxagliptin—Hypersensitivity—Alendronate—osteoporosis	0.000506	0.00195	CcSEcCtD
Saxagliptin—Headache—Etidronic acid—osteoporosis	0.000505	0.00195	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000502	0.00194	CcSEcCtD
Saxagliptin—Asthenia—Estropipate—osteoporosis	0.0005	0.00193	CcSEcCtD
Saxagliptin—Myalgia—Zoledronate—osteoporosis	0.000499	0.00193	CcSEcCtD
Saxagliptin—Arthralgia—Zoledronate—osteoporosis	0.000499	0.00193	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000496	0.00192	CcSEcCtD
Saxagliptin—Pruritus—Estropipate—osteoporosis	0.000493	0.00191	CcSEcCtD
Saxagliptin—Asthenia—Alendronate—osteoporosis	0.000493	0.0019	CcSEcCtD
Saxagliptin—Hypersensitivity—Ibandronate—osteoporosis	0.000493	0.0019	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000488	0.00189	CcSEcCtD
Saxagliptin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000487	0.00188	CcSEcCtD
Saxagliptin—Pruritus—Alendronate—osteoporosis	0.000486	0.00188	CcSEcCtD
Saxagliptin—Dyspepsia—Risedronate—osteoporosis	0.000485	0.00187	CcSEcCtD
Saxagliptin—Hypersensitivity—Calcitriol—osteoporosis	0.000482	0.00186	CcSEcCtD
Saxagliptin—Myalgia—Conjugated Estrogens—osteoporosis	0.000481	0.00186	CcSEcCtD
Saxagliptin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000481	0.00186	CcSEcCtD
Saxagliptin—Asthenia—Ibandronate—osteoporosis	0.00048	0.00185	CcSEcCtD
Saxagliptin—Nausea—Etidronic acid—osteoporosis	0.000479	0.00185	CcSEcCtD
Saxagliptin—Anaphylactic shock—Zoledronate—osteoporosis	0.000479	0.00185	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000477	0.00184	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000477	0.00184	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000476	0.00184	CcSEcCtD
Saxagliptin—Infection—Zoledronate—osteoporosis	0.000475	0.00184	CcSEcCtD
Saxagliptin—Fatigue—Risedronate—osteoporosis	0.000475	0.00184	CcSEcCtD
Saxagliptin—Pruritus—Ibandronate—osteoporosis	0.000473	0.00183	CcSEcCtD
Saxagliptin—Asthenia—Calcitriol—osteoporosis	0.00047	0.00181	CcSEcCtD
Saxagliptin—Immune system disorder—Estradiol—osteoporosis	0.000469	0.00181	CcSEcCtD
Saxagliptin—Thrombocytopenia—Zoledronate—osteoporosis	0.000469	0.00181	CcSEcCtD
Saxagliptin—Skin disorder—Zoledronate—osteoporosis	0.000465	0.0018	CcSEcCtD
Saxagliptin—Pruritus—Calcitriol—osteoporosis	0.000463	0.00179	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000462	0.00179	CcSEcCtD
Saxagliptin—Dyspepsia—Pamidronate—osteoporosis	0.000461	0.00178	CcSEcCtD
Saxagliptin—Dizziness—Estropipate—osteoporosis	0.000461	0.00178	CcSEcCtD
Saxagliptin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000461	0.00178	CcSEcCtD
Saxagliptin—Infection—Conjugated Estrogens—osteoporosis	0.000458	0.00177	CcSEcCtD
Saxagliptin—Dizziness—Alendronate—osteoporosis	0.000454	0.00175	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000452	0.00175	CcSEcCtD
Saxagliptin—Malnutrition—Estradiol—osteoporosis	0.000452	0.00175	CcSEcCtD
Saxagliptin—Fatigue—Pamidronate—osteoporosis	0.000452	0.00174	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Risedronate—osteoporosis	0.000451	0.00174	CcSEcCtD
Saxagliptin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000449	0.00173	CcSEcCtD
Saxagliptin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000448	0.00173	CcSEcCtD
Saxagliptin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000447	0.00173	CcSEcCtD
Saxagliptin—Dizziness—Raloxifene—osteoporosis	0.000447	0.00173	CcSEcCtD
Saxagliptin—Flatulence—Estradiol—osteoporosis	0.000445	0.00172	CcSEcCtD
Saxagliptin—Vomiting—Estropipate—osteoporosis	0.000443	0.00171	CcSEcCtD
Saxagliptin—Dizziness—Ibandronate—osteoporosis	0.000442	0.00171	CcSEcCtD
Saxagliptin—Rash—Estropipate—osteoporosis	0.00044	0.0017	CcSEcCtD
Saxagliptin—Dermatitis—Estropipate—osteoporosis	0.000439	0.0017	CcSEcCtD
Saxagliptin—Urticaria—Risedronate—osteoporosis	0.000438	0.00169	CcSEcCtD
Saxagliptin—Headache—Estropipate—osteoporosis	0.000437	0.00169	CcSEcCtD
Saxagliptin—Vomiting—Alendronate—osteoporosis	0.000437	0.00169	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000436	0.00168	CcSEcCtD
Saxagliptin—Abdominal pain—Risedronate—osteoporosis	0.000436	0.00168	CcSEcCtD
Saxagliptin—Rash—Alendronate—osteoporosis	0.000433	0.00167	CcSEcCtD
Saxagliptin—Dermatitis—Alendronate—osteoporosis	0.000433	0.00167	CcSEcCtD
Saxagliptin—Headache—Alendronate—osteoporosis	0.00043	0.00166	CcSEcCtD
Saxagliptin—Vomiting—Raloxifene—osteoporosis	0.00043	0.00166	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000428	0.00165	CcSEcCtD
Saxagliptin—Rash—Raloxifene—osteoporosis	0.000426	0.00165	CcSEcCtD
Saxagliptin—Dermatitis—Raloxifene—osteoporosis	0.000426	0.00164	CcSEcCtD
Saxagliptin—Vomiting—Ibandronate—osteoporosis	0.000425	0.00164	CcSEcCtD
Saxagliptin—Headache—Raloxifene—osteoporosis	0.000423	0.00163	CcSEcCtD
Saxagliptin—Rash—Ibandronate—osteoporosis	0.000422	0.00163	CcSEcCtD
Saxagliptin—Dermatitis—Ibandronate—osteoporosis	0.000421	0.00163	CcSEcCtD
Saxagliptin—Dyspepsia—Zoledronate—osteoporosis	0.000421	0.00163	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00042	0.00162	CcSEcCtD
Saxagliptin—Headache—Ibandronate—osteoporosis	0.000419	0.00162	CcSEcCtD
Saxagliptin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000417	0.00161	CcSEcCtD
Saxagliptin—Vomiting—Calcitriol—osteoporosis	0.000416	0.00161	CcSEcCtD
Saxagliptin—Nausea—Estropipate—osteoporosis	0.000414	0.0016	CcSEcCtD
Saxagliptin—Abdominal pain—Pamidronate—osteoporosis	0.000414	0.0016	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000413	0.0016	CcSEcCtD
Saxagliptin—Angioedema—Estradiol—osteoporosis	0.000413	0.00159	CcSEcCtD
Saxagliptin—Rash—Calcitriol—osteoporosis	0.000413	0.00159	CcSEcCtD
Saxagliptin—Fatigue—Zoledronate—osteoporosis	0.000413	0.00159	CcSEcCtD
Saxagliptin—Dermatitis—Calcitriol—osteoporosis	0.000412	0.00159	CcSEcCtD
Saxagliptin—Headache—Calcitriol—osteoporosis	0.00041	0.00158	CcSEcCtD
Saxagliptin—Nausea—Alendronate—osteoporosis	0.000408	0.00158	CcSEcCtD
Saxagliptin—Hypersensitivity—Risedronate—osteoporosis	0.000406	0.00157	CcSEcCtD
Saxagliptin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000406	0.00157	CcSEcCtD
Saxagliptin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000406	0.00157	CcSEcCtD
Saxagliptin—Nausea—Raloxifene—osteoporosis	0.000401	0.00155	CcSEcCtD
Saxagliptin—Pruritus—Ethinyl Estradiol—osteoporosis	0.0004	0.00154	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000398	0.00154	CcSEcCtD
Saxagliptin—Fatigue—Conjugated Estrogens—osteoporosis	0.000397	0.00153	CcSEcCtD
Saxagliptin—Nausea—Ibandronate—osteoporosis	0.000397	0.00153	CcSEcCtD
Saxagliptin—Asthenia—Risedronate—osteoporosis	0.000395	0.00153	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000391	0.00151	CcSEcCtD
Saxagliptin—Pruritus—Risedronate—osteoporosis	0.00039	0.00151	CcSEcCtD
Saxagliptin—Nausea—Calcitriol—osteoporosis	0.000389	0.0015	CcSEcCtD
Saxagliptin—Hypersensitivity—Pamidronate—osteoporosis	0.000386	0.00149	CcSEcCtD
Saxagliptin—Arthralgia—Estradiol—osteoporosis	0.000385	0.00149	CcSEcCtD
Saxagliptin—Myalgia—Estradiol—osteoporosis	0.000385	0.00149	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000382	0.00148	CcSEcCtD
Saxagliptin—Urticaria—Zoledronate—osteoporosis	0.00038	0.00147	CcSEcCtD
Saxagliptin—Abdominal pain—Zoledronate—osteoporosis	0.000378	0.00146	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000377	0.00146	CcSEcCtD
Saxagliptin—Asthenia—Pamidronate—osteoporosis	0.000376	0.00145	CcSEcCtD
Saxagliptin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000374	0.00144	CcSEcCtD
Saxagliptin—Pruritus—Pamidronate—osteoporosis	0.000371	0.00143	CcSEcCtD
Saxagliptin—Anaphylactic shock—Estradiol—osteoporosis	0.000369	0.00142	CcSEcCtD
Saxagliptin—Infection—Estradiol—osteoporosis	0.000366	0.00142	CcSEcCtD
Saxagliptin—Urticaria—Conjugated Estrogens—osteoporosis	0.000366	0.00141	CcSEcCtD
Saxagliptin—Dizziness—Risedronate—osteoporosis	0.000364	0.00141	CcSEcCtD
Saxagliptin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000364	0.00141	CcSEcCtD
Saxagliptin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000359	0.00139	CcSEcCtD
Saxagliptin—Skin disorder—Estradiol—osteoporosis	0.000358	0.00138	CcSEcCtD
Saxagliptin—Rash—Ethinyl Estradiol—osteoporosis	0.000356	0.00138	CcSEcCtD
Saxagliptin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000356	0.00138	CcSEcCtD
Saxagliptin—Headache—Ethinyl Estradiol—osteoporosis	0.000354	0.00137	CcSEcCtD
Saxagliptin—Hypersensitivity—Zoledronate—osteoporosis	0.000353	0.00136	CcSEcCtD
Saxagliptin—Vomiting—Risedronate—osteoporosis	0.00035	0.00135	CcSEcCtD
Saxagliptin—Rash—Risedronate—osteoporosis	0.000348	0.00134	CcSEcCtD
Saxagliptin—Dermatitis—Risedronate—osteoporosis	0.000347	0.00134	CcSEcCtD
Saxagliptin—Dizziness—Pamidronate—osteoporosis	0.000346	0.00134	CcSEcCtD
Saxagliptin—Headache—Risedronate—osteoporosis	0.000345	0.00133	CcSEcCtD
Saxagliptin—Asthenia—Zoledronate—osteoporosis	0.000343	0.00133	CcSEcCtD
Saxagliptin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00034	0.00131	CcSEcCtD
Saxagliptin—Pruritus—Zoledronate—osteoporosis	0.000339	0.00131	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000336	0.0013	CcSEcCtD
Saxagliptin—Nausea—Ethinyl Estradiol—osteoporosis	0.000336	0.0013	CcSEcCtD
Saxagliptin—Vomiting—Pamidronate—osteoporosis	0.000333	0.00129	CcSEcCtD
Saxagliptin—Asthenia—Conjugated Estrogens—osteoporosis	0.000331	0.00128	CcSEcCtD
Saxagliptin—Rash—Pamidronate—osteoporosis	0.00033	0.00128	CcSEcCtD
Saxagliptin—Dermatitis—Pamidronate—osteoporosis	0.00033	0.00127	CcSEcCtD
Saxagliptin—Headache—Pamidronate—osteoporosis	0.000328	0.00127	CcSEcCtD
Saxagliptin—Nausea—Risedronate—osteoporosis	0.000327	0.00126	CcSEcCtD
Saxagliptin—Pruritus—Conjugated Estrogens—osteoporosis	0.000326	0.00126	CcSEcCtD
Saxagliptin—Dyspepsia—Estradiol—osteoporosis	0.000325	0.00125	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000318	0.00123	CcSEcCtD
Saxagliptin—Fatigue—Estradiol—osteoporosis	0.000318	0.00123	CcSEcCtD
Saxagliptin—Dizziness—Zoledronate—osteoporosis	0.000316	0.00122	CcSEcCtD
Saxagliptin—Nausea—Pamidronate—osteoporosis	0.000311	0.0012	CcSEcCtD
Saxagliptin—Dizziness—Conjugated Estrogens—osteoporosis	0.000305	0.00118	CcSEcCtD
Saxagliptin—Vomiting—Zoledronate—osteoporosis	0.000304	0.00118	CcSEcCtD
Saxagliptin—Rash—Zoledronate—osteoporosis	0.000302	0.00117	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Estradiol—osteoporosis	0.000302	0.00116	CcSEcCtD
Saxagliptin—Dermatitis—Zoledronate—osteoporosis	0.000301	0.00116	CcSEcCtD
Saxagliptin—Headache—Zoledronate—osteoporosis	0.0003	0.00116	CcSEcCtD
Saxagliptin—Vomiting—Conjugated Estrogens—osteoporosis	0.000293	0.00113	CcSEcCtD
Saxagliptin—Urticaria—Estradiol—osteoporosis	0.000293	0.00113	CcSEcCtD
Saxagliptin—Abdominal pain—Estradiol—osteoporosis	0.000292	0.00113	CcSEcCtD
Saxagliptin—Rash—Conjugated Estrogens—osteoporosis	0.000291	0.00112	CcSEcCtD
Saxagliptin—Dermatitis—Conjugated Estrogens—osteoporosis	0.00029	0.00112	CcSEcCtD
Saxagliptin—Headache—Conjugated Estrogens—osteoporosis	0.000289	0.00112	CcSEcCtD
Saxagliptin—Nausea—Zoledronate—osteoporosis	0.000284	0.0011	CcSEcCtD
Saxagliptin—Nausea—Conjugated Estrogens—osteoporosis	0.000274	0.00106	CcSEcCtD
Saxagliptin—Hypersensitivity—Estradiol—osteoporosis	0.000272	0.00105	CcSEcCtD
Saxagliptin—Asthenia—Estradiol—osteoporosis	0.000265	0.00102	CcSEcCtD
Saxagliptin—Pruritus—Estradiol—osteoporosis	0.000261	0.00101	CcSEcCtD
Saxagliptin—Dizziness—Estradiol—osteoporosis	0.000244	0.000942	CcSEcCtD
Saxagliptin—Vomiting—Estradiol—osteoporosis	0.000235	0.000906	CcSEcCtD
Saxagliptin—Rash—Estradiol—osteoporosis	0.000233	0.000898	CcSEcCtD
Saxagliptin—Dermatitis—Estradiol—osteoporosis	0.000232	0.000897	CcSEcCtD
Saxagliptin—Headache—Estradiol—osteoporosis	0.000231	0.000892	CcSEcCtD
Saxagliptin—Nausea—Estradiol—osteoporosis	0.000219	0.000846	CcSEcCtD
